Lovastatin
Product Images NDC 53002-5701

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 53002-5701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin Structural Formula (Image 1)

Chemical structure of lovastatin, depicting its molecular arrangement including rings and functional groups, as shown in a black and white diagram.*

FDA Label Image

Figure 1: Actue Major Coronary Events (primary Endpoint) (Image 2)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over a 6-year follow-up. Two lines compare Lovastatin and placebo, indicating a 37% risk reduction in the Lovastatin group (p < 0.001). The y-axis represents the proportion of participants without event, and the x-axis shows years of follow-up.*

FDA Label Image

Label Image (Lbl530025701)

Lovastatin 20 mg tablets packaging label from RPK Pharmaceuticals, Inc., showing a carton and container label for a 100-tablet bottle. The label includes directions to take one tablet daily or as directed, features a blue round tablet image, and space for prescriber and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.